Global Oxycodone Market Professional Survey Report 2019

2 Global Oxycodone Quarterly Market Size Analysis

• 2.1 Oxycodone Business Impact Assessment - COVID-19
  • 2.1.1 Global Oxycodone Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  • 2.1.2 Global Oxycodone Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
• 2.2 Global Oxycodone Quarterly Market Size 2020-2021
• 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  • 2.3.1 Drivers
  • 2.3.2 Restraints
  • 2.3.3 Opportunities
  • 2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020

• 3.1 Global Oxycodone Quarterly Market Size by Manufacturers, 2019 VS 2020
• 3.2 Global Oxycodone Factory Price by Manufacturers
• 3.3 Location of Key Manufacturers Oxycodone Manufacturing Factories and Area Served
• 3.4 Date of Key Manufacturers Enter into Oxycodone Market
• 3.5 Key Manufacturers Oxycodone Product Offered
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Oxycodone Segments, By Type

• 4.1 Introduction
  • 1.4.1 Long Acting Oxycodone
  • 1.4.2 Short Acting Oxycodone
• 4.2 By Type, Global Oxycodone Market Size, 2019-2021
  • 4.2.1 By Type, Global Oxycodone Market Size by Type, 2020-2021
  • 4.2.2 By Type, Global Oxycodone Price, 2020-2021

5 Impact of Covid-19 on Oxycodone Segments, By Application

• 5.1 Overview
  • 5.5.1 Hospital Pharmacies
  • 5.5.2 Retail Pharmacies
  • 5.5.3 Others
• 5.2 By Application, Global Oxycodone Market Size, 2019-2021
  • 5.2.1 By Application, Global Oxycodone Market Size by Application, 2019-2021
  • 5.2.2 By Application, Global Oxycodone Price, 2020-2021

6 Geographic Analysis

• 6.1 Introduction
• 6.2 North America
  • 6.2.1 Macroeconomic Indicators of US
  • 6.2.2 US
  • 6.2.3 Canada
• 6.3 Europe
  • 6.3.1 Macroeconomic Indicators of Europe
  • 6.3.2 Germany
  • 6.3.3 France
  • 6.3.4 UK
  • 6.3.5 Italy
• 6.4 Asia-Pacific
  • 6.4.1 Macroeconomic Indicators of Asia-Pacific
  • 6.4.2 China
  • 6.4.3 Japan
  • 6.4.4 South Korea
  • 6.4.5 India
  • 6.4.6 ASEAN
• 6.5 Rest of World
  • 6.5.1 Latin America
  • 6.5.2 Middle East and Africa

7 Company Profiles

• 7.1 Johnson & Johnson
  • 7.1.1 Johnson & Johnson Business Overview
  • 7.1.2 Johnson & Johnson Oxycodone Quarterly Production and Revenue, 2020
  • 7.1.3 Johnson & Johnson Oxycodone Product Introduction
  • 7.1.4 Johnson & Johnson Response to COVID-19 and Related Developments
• 7.2 Sanofi
  • 7.2.1 Sanofi Business Overview
  • 7.2.2 Sanofi Oxycodone Quarterly Production and Revenue, 2020
  • 7.2.3 Sanofi Oxycodone Product Introduction
  • 7.2.4 Sanofi Response to COVID-19 and Related Developments
• 7.3 Pfizer
  • 7.3.1 Pfizer Business Overview
  • 7.3.2 Pfizer Oxycodone Quarterly Production and Revenue, 2020
  • 7.3.3 Pfizer Oxycodone Product Introduction
  • 7.3.4 Pfizer Response to COVID-19 and Related Developments
• 7.4 Purdue Pharma
  • 7.4.1 Purdue Pharma Business Overview
  • 7.4.2 Purdue Pharma Oxycodone Quarterly Production and Revenue, 2020
  • 7.4.3 Purdue Pharma Oxycodone Product Introduction
  • 7.4.4 Purdue Pharma Response to COVID-19 and Related Developments
• 7.5 Endo International
  • 7.5.1 Endo International Business Overview
  • 7.5.2 Endo International Oxycodone Quarterly Production and Revenue, 2020
  • 7.5.3 Endo International Oxycodone Product Introduction
  • 7.5.4 Endo International Response to COVID-19 and Related Developments
• 7.6 Teva Pharmaceuticals
  • 7.6.1 Teva Pharmaceuticals Business Overview
  • 7.6.2 Teva Pharmaceuticals Oxycodone Quarterly Production and Revenue, 2020
  • 7.6.3 Teva Pharmaceuticals Oxycodone Product Introduction
  • 7.6.4 Teva Pharmaceuticals Response to COVID-19 and Related Developments
• 7.7 Hikma Pharmaceuticals (West-Ward Pharmaceuticals)
  • 7.7.1 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Business Overview
  • 7.7.2 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Quarterly Production and Revenue, 2020
  • 7.7.3 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Oxycodone Product Introduction
  • 7.7.4 Hikma Pharmaceuticals (West-Ward Pharmaceuticals) Response to COVID-19 and Related Developments
• 7.8 Mallinckrodt
  • 7.8.1 Mallinckrodt Business Overview
  • 7.8.2 Mallinckrodt Oxycodone Quarterly Production and Revenue, 2020
  • 7.8.3 Mallinckrodt Oxycodone Product Introduction
  • 7.8.4 Mallinckrodt Response to COVID-19 and Related Developments
• 7.9 Mylan
  • 7.9.1 Mylan Business Overview
  • 7.9.2 Mylan Oxycodone Quarterly Production and Revenue, 2020
  • 7.9.3 Mylan Oxycodone Product Introduction
  • 7.9.4 Mylan Response to COVID-19 and Related Developments
• 7.10 Sun Pharmaceutical (Chattem Chemicals)
  • 7.10.1 Sun Pharmaceutical (Chattem Chemicals) Business Overview
  • 7.10.2 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Quarterly Production and Revenue, 2020
  • 7.10.3 Sun Pharmaceutical (Chattem Chemicals) Oxycodone Product Introduction
  • 7.10.4 Sun Pharmaceutical (Chattem Chemicals) Response to COVID-19 and Related Developments
• 7.11 Impax Laboratories
  • 7.11.1 Impax Laboratories Business Overview
  • 7.11.2 Impax Laboratories Oxycodone Quarterly Production and Revenue, 2020
  • 7.11.3 Impax Laboratories Oxycodone Product Introduction
  • 7.11.4 Impax Laboratories Response to COVID-19 and Related Developments
• 7.12 Indivior
  • 7.12.1 Indivior Business Overview
  • 7.12.2 Indivior Oxycodone Quarterly Production and Revenue, 2020
  • 7.12.3 Indivior Oxycodone Product Introduction
  • 7.12.4 Indivior Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis

• 8.1 Oxycodone Supply Chain Analysis
  • 8.1.1 Oxycodone Supply Chain Analysis
  • 8.1.2 Covid-19 Impact on Oxycodone Supply Chain
• 8.2 Distribution Channels Analysis
  • 8.2.1 Oxycodone Distribution Channels
  • 8.2.2 Covid-19 Impact on Oxycodone Distribution Channels
  • 8.2.3 Oxycodone Distributors
• 8.3 Oxycodone Customers

9 Key Findings

10 Appendix

• 10.1 About Us